Clinical Trial Update: Vytorin Reexamination Study (0653A-174)

View source ↗

Summary

Clinical trial update for the Vytorin reexamination study (0653A-174) completed with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Homozygous Familial Hypercholesterolemia
• Hypercholesterolemia

Drugs mentioned

• Vytorin (ezetimibe/simvastatin)

Snippet

Sponsor: Organon and Co | Conditions: Primary Hypercholesterolemia and Homozygous Familial Hypercholesterolemia (HoFH) | Status: COMPLETED | Results posted: 2011-05-10